Project CARE: CAncer Risk Evaluation

Part of paid clinical trials in New Brunswick, New Jersey.

Sponsor
Anita Y. Kinney, PhD, RN
Study ID
NCT07130487
Status
Recruiting
Apply to this trial

Conditions

  • Primary Care

Eligibility Criteria

Sex
ALL
Age
18 Years - 70 Years
Healthy Volunteers
Accepted

Interventions

  • Relational Agent ( RA) Alex — BEHAVIORAL
    The intervention is an RA (chatbot) integrated into a genetic care delivery portal for primary care patients. The RA provides hereditary cancer education and risk evaluation through an interactive interface. Primary care patients will use the RA to complete questionnaires about their hereditary cancer risk, track their progress through the education component and assessment process, and obtain downloadable summaries of their cancer risk and family tree. Additionally, the chat feature stores past conversations, and a menu guides participants through key steps.

Study Details

The purpose of Project CARE (cancer risk assessment and evaluation) research study is to explore the acceptance and feasibility of a study-initiated proactive outreach and digital care delivery model for conducting hereditary cancer risk assessment in primary care settings and facilitating genetic risk evaluation for patients flagged as high risk. Potential participants will be recruited from Rutgers Health primary care sites (family practice and general internal medicine). EPIC will be used to identify all potential participants and they will be invited to participate in the study. Consented participants will be provided a link via email, and or text message to engage with a Relational Agent (RA, chatbot), through the patient portal for cancer risk assessment and genetic education. Those identified as high risk will be offered genetic counseling and testing. The research questions the study aims to answer are: 1. What percent of patients who completed the RA are identified as high risk? 2. What percent of patients who engaged with the risk assessment were identified as high risk? 3. What percent of high-risk patients had genetic counseling or genetic testing within 4 months of completing the risk assessment?

Key Dates

Start date
Nov 19, 2025
Status verified
Nov 2025
Primary completion
Nov 30, 2026
Completion
Nov 30, 2026

Study Design

Enrollment
210 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING

Arms

  • Experimental: Feasibility and Acceptability of Relational Agent Chatbot

Primary Outcome Measure

Proportion of Patients Completing the Hereditary Cancer Risk Assessment [ Time Frame: Up to 3 months from enrollment ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Rutgers, The State University of New JerseyNew BrunswickNew Jersey08901
Julie Chapman-Greene, PhD, MPH
[email protected]
732-865-3375
Anita Y Kinney, PhD, RN (PRINCIPAL_INVESTIGATOR)

Find similar trials in New Brunswick, NJ

By research site
Rutgers, The State University of New Jersey· New Brunswick, NJ

Related Studies